Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 388.25
+1.85 (0.48%)
May 16, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €99.72 billion as of May 16, 2025. Its market cap has increased by 5.03% in one year.
Market Cap
99.72B
Enterprise Value
91.04B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€388.25
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 99.72B, an increase of 134,874.25%. That is a compound annual growth rate of 23.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 54.52B |
| Merck KGaA | 50.17B |
| Fresenius SE & Co. KGaA | 23.95B |
| Bayer Aktiengesellschaft | 22.46B |
| Fresenius Medical Care AG | 14.92B |
| Sartorius Aktiengesellschaft | 14.31B |
| Carl Zeiss Meditec AG | 5.36B |
| Fielmann Group AG | 4.67B |